Main Article

Burlington, N.C.-based LabCorp has announced plans to partner with National Jewish Health (NJH, Denver) hospital system to develop and market molecular diagnostic tests. This is not a testing service joint-venture partnership, but rather focused on bringing companion diagnostics to market, most likely in the area of cardiology-, respiratory-, and immune-related diseases that NJH calls its "core clinical areas of excellence."

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

January 2009 - Table of Contents

LIR January 2009 (full PDF issue)

G-2 Predicts Lab Industry to Grow 6.7% to $58.8B in 2009, Independent Labs’ Growth to Outpace Quest & LabCorp Through 2013

California Attorney General Investigating Labs for Improper Billing

Analysts Tell Genoptix to Grow Sales, Pathology Staff to Expand 5%-6% Market Share

LabCorp Teams With Denver’s National Jewish Health for Mol Dx Development

Inside the Lab Industry: National Players Might Be Winning the Revenue Battle, but Independents Are Conquering the Growth Battle

BloodCenter of Wisconsin’s New Molecular Oncology Lab Enters Hematopathology Market

Washington Hospital Center’s Lab Using Lean to Cut DSO from 78 to 40 Days

Detroit’s St. John Puts Outreach Business up for Sale

Gamma-Dynacare Expands Into Manitoba With Acquisition of Central Medical Labs

Labs Experience Slight December Rebound; Stocks up 4% Over Past 5 Weeks

Sunquest Buys PAML’s Outreach Advantage

Washington G-2 Reports/Slone Partners Survey Finds Average Senior Lab Sales and Marketing Salaries Currently at $81K to $160K